Search Results - "Garcia‐Garzon, S."

Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full‐Dose Peg‐Interferon and Ribavirin by Oton, E., Barcena, R., Moreno‐Planas, J. M., Cuervas‐Mons, V., Moreno‐Zamora, A., Barrios, C., Garcia‐Garzon, S., Moreno, A., Boullosa‐Graña, E., Rubio‐Gonzalez, E. E., Garcia‐Gonzalez, M., Blesa, C., Mateos, M. L.

“…Hepatitis C recurrence after liver transplantation (LT) is universal, and frequently leads to cirrhosis and death. The aim of our study was to assess the…”
Get full text

Mercaptopurine rescue after azathioprine‐induced liver injury in inflammatory bowel disease by BERMEJO, F., LÓPEZ‐SANROMÁN, A., ALGABA, A., VAN‐DOMSELAAR, M., GISBERT, J. P., GARCÍA‐GARZÓN, S., GARRIDO, E., PIQUERAS, B., DE LA POZA, G., GUERRA, I.

“…Summary Background  Azathioprine (AZA) liver toxicity arises in approximately 3% of inflammatory bowel disease patients and may result in treatment…”
Get full text

Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus by Moreno, A, Bárcena, R, García-Garzón, S, Moreno, L, Quereda, C, Muriel, A, Zamora, J, Mateos, M L, Pérez-Elías, M J, Antela, A, Diz, S, Moreno, A, Moreno, S

“…To evaluate, among 70 hepatitis C virus (HCV)-monoinfected and 36 human immunodeficiency virus (HIV)-coinfected naïve patients with genotypes 1/4 receiving…”
Get full text

601 PEG-INTERFERON-ALPHA PLUS RIBAVIRIN TREATMENT INDUCES A CENTRAL MEMORY SPECIFIC CD8+ T CELL RESERVOIR IN CHRONIC HEPATITIS C PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE by Benito, S, Larrubia, J.R, Sanz-de-Villalobos, E, Calvino, M, Garcia-Buey, M.L, Garcia-Garzon, S, Gonzalez-Mateos, F, Gonzalez-Praetorius, A, Miquel, J, Bienvenido, A, Parra, T

Get full text

119 NEGATIVE COSTIMULATORY MOLECULE PD1 UP-REGULATION ON CD8+ CELLS DURING PERSISTENT HCV INFECTION by Benito, S, Larrubia, J.R, Sanz-de-Villalobos, E, Calvino, M, Garcia-Buey, M.L, Garcia-Garzon, S, Gonzalez-Mateos, F, Gonzalez-Praetorius, A, Miquel, J, Bienvenido, A, Parra, T

Get full text

Pegylated Interferon and Ribavirin for the Recurrence of Chronic Hepatitis C Genotype 1 in Transplant Patients by Oton, E., Barcena, R., Garcia-Garzon, S., Moreno-Zamora, A., Moreno, A., Garcia-Gonzalez, M., Blesa, C., Foruny, J.R., Ruiz, P.

“…The efficacy of pegylated interferon (p-IFN) and ribavirin (RB) in transplant patients is not well known. Chronic hepatitis C evolves in a more aggressive form…”
Get full text

[447] ROLE OF CCR5 AND CXCR3 CHEMOKINE RECEPTORS EXPRESSION ON CD8+ CELLS DURING CHRONIC HEPATITIS C INFECTION by Calvino, M, Benito, S, Parra, T, Perez de Hornedo, J, Arias, A, Sanz de Villalobos, E, Gonzalez-Mateos, F, Garcia-Garzon, S, Perna, C, Bienvenido, A, Larrubia, J.R

Get full text

Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation by Larrubia, J. R., Lokhande, M. U., García-Garzón, S., Miquel, J., González-Praetorius, A., Parra-Cid, T., Sanz-de-Villalobos, E.

“…In persistent hepatitis C virus (HCV) infection, HCV‐specific cytotoxic T lymphocyte (CTL) reactivity is impaired and this affects HCV control. Interleukin‐7…”
Get full text

P0506 : Impaired HCV-specific cytotoxic T cell reactivity due to 4-1BB signalling adapter (TRAF1) down-regulation during persistent HCV infection is restored by IL-7 plus 4-1BBL treatment by Moreno-Cubero, E, Sanz-de-Villalobos, E, Míquel, J, Borobia, R, García-Garzón, S, Lázaro, A, González-Pretorious, A, Perna, C, Torralba, M, Hocine, T, Larrubia, J.R

Get full text

HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin by Moreno, Ana, Bárcena, Rafael, García-Garzón, Silvia, Muriel, Alfonso, Quereda, Carmen, Moreno, Leonor, Mateos, María L, Fortún, Jesús, Martín-Dávila, Pilar, García, Miguel, Blesa, Carlos, Otón, Elena, Moreno, Alberto, Moreno, Santiago

“…Differences in HCV-RNA clearance during therapy might explain the lower efficacy of peg-IFN/RBV in HIV/HCV-coinfection. There are limited data on HCV-RNA…”
Get full text

344 PERIPHERAL HCV-SPECIFIC CYTOTOXIC RESPONSE DETECTION AT WEEK 12 OF PEGYLATED-INTERFERON alfa-2b PLUS RIBAVIRIN TREATMENT FOR CHRONIC HCV INFECTION CORRELATES WITH SUSTAINED VIROLOGIC RESPONSE DEVELOPMENT by Larrubia, J.R, Lokhande, M.U, Miquel, J, García-Garzón, S, González-Praetorious, A, Sanz-de-Villalobos, E

Get full text

P121 VIRAL LOAD DECREASE HIGHER THAN 3 LOG AT WEEK 12 OF PEG-INTERFERON ALFA-2b/RIBAVIRIN HCV TREATMENT CORRELATES WITH HCV-SPECIFIC CYTOTOXIC T CELL RESPONSE RESTORATION by Moreno-Cubero, E, Miquel, J, García-Garzón, S, Lázaro, A, Gonzalez-Praetorious, A, Perna, C, Sanz-de-Villalobos, E, Larrubia, J.R

Get full text

P122 IMPAIRED HCV-SPECIFIC CTL REACTIVITY DUE TO APOPTOSIS INDUCTION DURING CHRONIC INFECTION IS NOT RESTORED BY IL-7 TREATMENT by Moreno-Cubero, E, García-Garzón, S, Miquel, J, Sanz-de-Villalobos, E, Lázaro, A, González-Praetorious, A, Perna, C, Larrubia, J.R

Get full text

795 HCV-SPECIFIC CYTOTOXIC RESPONSE RESTORATION IS AN EXCELENT PREDICTOR OF SUSTAINED VIROLOGIC RESPONSE IN PEG-INTERFERON-RIVABIRIN BASED TREATMENT by Larrubia, J.R, Lokhande, M.U, Parra-Cid, T, Miquel, J, García-Garzón, S, González-Praetorious, A, Sanz-de-Villalobos, E

Get full text

796 CD127LOW HCV-SPECIFIC CYTOTOXIC T CELL HYPOREACTIVITY DURING PERSISTENT INFECTION DEPENDS ON MCL-1/BIM RATIO by Larrubia, J.R, Lokhande, M.U, Parra-Cid, T, Miquel, J, García-Garzón, S, González-Praetorious, A, Sanz-de-Villalobos, E

Get full text

273 ENHANCEMENT OF CD127 HCV-SPECIFIC CYTOTOXIC RESPONSE THROUGH BIM-MEDIATED APOPTOSIS BLOCKING IN PERSISTENT HCV INFECTION by Larrubia, J.R, Benito, S, Lokhande, M, Miquel, J, Calvino, M, Sanz-de-Villalobos, E, González-Praetorious, A, Albertos, S, García-Garzón, S, Parra-Cid, T

Get full text

298 SUSTAINED VIROLOGIC RESPONSE IN HIGH VIRAEMIC GENOTYPE-1 HCV INFECTION CORRELATES WITH PERIPHERAL HCV-SPECIFIC CYTOTOXIC RESPONSE RESTORATION by Larrubia, J.R, Benito, S, Lokhande, M, Miquel, J, Calvino, M, Sanz-de-Villalobos, E, González-Praetorious, A, Albertos, S, García-Garzón, S, Parra-Cid, T

Get full text

272 DETECTION OF A HCV-SPECIFIC CYTOTOXIC RESPONSE DURING THE FIRST TWELVE WEEKS OF ANTI-HCV TREATMENT CORRELATES WITH SUSTAINED VIROLOGIC RESPONSE by Larrubia, J.R, Benito, S, Lokhande, M, Miquel, J, Calvino, M, Sanz-de-Villalobos, E, González-Praetorious, A, Albertos, S, García-Garzón, S, Parra-Cid, T

Get full text

345 PERSISTENT HEPATITIS C VIRUS (HCV) INFECTION IMPAIRS HCV-SPECIFIC CYTOTOXIC T CELL REACTIVITY THROUGH Mcl-1/Bim IMBALANCE DUE TO CD127 DOWN-REGULATION by Larrubia, J.R, Lokhande, M.U, García-Garzón, S, Miquel, J, González-Praetorious, A, Sanz-de-Villalobos, E

Get full text

Viral kinetics and early prediction of nonresponse to peg-IFN-α-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus by Moreno, A., Bárcena, R., García-Garzón, S., Moreno, L., Quereda, C., Muriel, A., Zamora, J., Mateos, M. L., Pérez-Elías, M. J., Antela, A., Diz, S., Moreno, A., Moreno, S.

“…To evaluate, among 70 hepatitis C virus (HCV)‐monoinfected and 36 human immunodeficiency virus (HIV)‐coinfected naïve patients with genotypes 1/4 receiving…”
Get full text